Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.71 |
| ▸ | MEN1 | O00255 | 6/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.71 |
| ▸ | HPGD | P15428 | 4/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.71 |
| ▸ | CYP1B1 | Q16678 | 7/20 | 0.67 |
| ▸ | MAPT | P10636 | 6/20 | 0.67 |
| ▸ | CYP1A1 | P04798 | 6/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.67 |
| ▸ | TSHR | P16473 | 2/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.67 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | TP53 | P04637 | 3/20 | 0.56 |
| ▸ | CA12 | O43570 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Karanjin SCHEMBL7164819 | 0.80 | KDM4E (1.00) | KDM4ECYP3A4MEN1KMT2AHSD17B10 | |
| Karanjin SCHEMBL247164 | 0.80 | KDM4E (1.00) | KDM4ECYP3A4MEN1KMT2AHSD17B10 | |
| SCHEMBL17292888 | 0.78 | ABCG2 (1.00) | KDM4ECYP3A4MEN1KMT2AHSD17B10 | |
| SCHEMBL31438664 | 0.78 | ABCG2 (0.68) | KDM4ECYP3A4MEN1KMT2AHSD17B10 | |
| SCHEMBL5569925 | 0.78 | ABCG2 (0.68) | KDM4ECYP3A4MEN1KMT2AHSD17B10 | |
| SCHEMBL26603564 | 0.78 | CYP1A1 (0.59) | KDM4ECYP3A4MEN1KMT2AHSD17B10 | |
| SCHEMBL2747101 | 0.75 | CYP3A4 (0.63) | KDM4ECYP3A4MEN1KMT2AHSD17B10 | |
| SCHEMBL31290902 | 0.75 | ABCG2 (0.68) | KDM4ECYP3A4MEN1KMT2AHSD17B10 | |
| SCHEMBL9836522 | 0.73 | CYP1A1 (0.57) | KDM4ECYP3A4HSD17B10HPGDALDH1A1 | |
| SCHEMBL15676500 | 0.72 | ABCG2 (0.65) | KDM4ECYP3A4MEN1KMT2AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12610971-B2 | Pongamia compositions, methods of preparing and analyzing thereof, and uses thereof | TerViva BioEnergy, Inc. (US) | 2026-04-28 | — | — | US | claimed |
| US-12610971-B2 | Pongamia compositions, methods of preparing and analyzing thereof, and uses thereof | TerViva BioEnergy, Inc. (US) | 2026-04-28 | — | — | US | disclosed |
| US-12052994-B2 | Methods for controlling black sigatoka in bananas using pongamia oil and formulations thereof | Terviva, Inc. (US) | 2024-08-06 | — | — | US | disclosed |
| CN-113473863-B | Method for controlling black leaf spot in bananas using water yellow oil and its formulation | 特尔维瓦股份有限公司 | 2023-10-03 | — | — | CN | disclosed |
| US-20220369662-A1 | EDIBLE PONGAMIA COMPOSITIONS, AND METHODS OF PREPARING AND USING THEREOF | Terviva, Inc. (US) | 2022-11-24 | — | — | US | disclosed |
| EP-4037491-A1 | EDIBLE PONGAMIA COMPOSITIONS, AND METHODS OF PREPARING AND USING THEREOF | TerViva, Inc. (US) | 2022-08-10 | — | — | EP | disclosed |
| CN-114745965-A | Edible buffalo peel composition, preparation method and application thereof | 特尔维瓦股份有限公司 | 2022-07-12 | — | — | CN | disclosed |
| US-20220125059-A1 | METHODS FOR CONTROLLING BLACK SIGATOKA IN BANANAS USING PONGAMIA OIL AND FORMULATIONS THEREOF | Terviva, Inc. (US) | 2022-04-28 | — | — | US | disclosed |
| US-20220000146-A1 | PONGAMIA COMPOSITIONS, METHODS OF PREPARING AND ANALYZING THEREOF, AND USES THEREOF | Terviva, Inc. (US) | 2022-01-06 | — | — | US | disclosed |
| CN-113473863-A | Method for controlling black leaf spot in bananas using wampee oil and formulations thereof | 特尔维瓦股份有限公司 | 2021-10-01 | — | — | CN | disclosed |
| EP-3860358-A1 | PONGAMIA COMPOSITIONS, METHODS OF PREPARING AND ANALYZING THEREOF, AND USES THEREOF | Terviva Bioenergy, Inc. (US) | 2021-08-11 | — | — | EP | disclosed |
| CN-113194737-A | Pongamia composition, preparation and analysis method thereof and application thereof | 特尔维瓦生物能源股份有限公司 | 2021-07-30 | — | — | CN | disclosed |
| WO-2021067698-A1 | EDIBLE PONGAMIA COMPOSITIONS, AND METHODS OF PREPARING AND USING THEREOF | TerViva BioEnergy, Inc. (US) | 2021-04-08 | — | — | WO | disclosed |
| WO-2020160536-A1 | METHODS FOR CONTROLLING BLACK SIGATOKA IN BANANAS USING PONGAMIA OIL AND FORMULATIONS THEREOF | TerViva BioEnergy, Inc. (US) | 2020-08-06 | — | — | WO | disclosed |
| WO-2020072827-A1 | PONGAMIA COMPOSITIONS, METHODS OF PREPARING AND ANALYZING THEREOF, AND USES THEREOF | TerViva BioEnergy, Inc. (US) | 2020-04-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220125059-A1 | METHODS FOR CONTROLLING BLACK SIGATOKA IN BANANAS USING PONGAMIA OIL AND FORMULATIONS THEREOF | LIPA, SIGLEC7, AMY1A | KDM4E 3875/4885CYP3A4 2219/4885MEN1 4722/4885 |
| US-12610971-B2 | Pongamia compositions, methods of preparing and analyzing thereof, and uses thereof | DEK, DGKG, SRMS | KDM4E 1254/4885CYP3A4 2850/4885MEN1 4421/4885 |
| US-12052994-B2 | Methods for controlling black sigatoka in bananas using pongamia oil and formulations thereof | LIPA, SIGLEC7, AMY1A | KDM4E 3875/4885CYP3A4 2219/4885MEN1 4722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.